Fulbright's IPO thwarted by major patent disputes with Johnson & Johnson
Chinese medical device maker Fulbright Medical Inc.’s plans to list on the Shanghai Stock Exchange (SSE) have been thwarted due to extensive patent litigation. The company's IPO application, which was accepted on June 30, 2023, has now been officially terminated.